Retatrutide Pen

The Retatrutide Pen is a pre-filled injection pen containing 4mg of Retatrutide, the novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors. This pen format offers a convenient, ready-to-use alternative to traditional vial and syringe reconstitution, ideal for streamlined research protocols.

The pen delivery system ensures precise dosing and eliminates the need for reconstitution with bacteriostatic water. Each pen contains 4mg of high-purity Retatrutide in a stable, pre-mixed solution. The triple-agonist mechanism addresses multiple metabolic pathways simultaneously, making this pen format particularly practical for extended research studies. This product is for research purposes only.